We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

A Pilot Study Testing the Efficacy of a Needling Device for the Treatment of Acne Scars

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00974870
Recruitment Status : Completed
First Posted : September 10, 2009
Last Update Posted : December 2, 2021
Information provided by (Responsible Party):
Murad Alam, Northwestern University

Brief Summary:
The primary objective of this study is to determine the efficacy of a needling device for treatment of acne scars.

Condition or disease Intervention/treatment Phase
Acne Scars Procedure: needling treatment Not Applicable

Detailed Description:

We are investigating a needled micro-roller for use in improving the appearance of acne scars. The study is being conducted under the direction of Dr. Murad Alam of Northwestern University, Department of Dermatology.

The needles on the micro-roller are designed to create small holes in the top and mid layers of skin in order to induce the formation of more collagen, which would in turn help improve the appearance of acne scars. To qualify for the study, you must have at least 2 large areas of the face with acne scars.

The study is designed such that one part of your face, which has acne scars, will be treated with the device on 3 separate occasions, spaced 2 weeks apart at our clinic in Chicago at Northwestern. We would also ask you to return at 3 months and at 6 months to have photographs taken.

If you are interested in participating, we would like to get you involved as soon as possible

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 20 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Split-face Randomized Controlled Trial to Assess the Efficacy of a Needling Device for the Treatment of Acne Scars
Study Start Date : November 2009
Actual Primary Completion Date : July 2010
Actual Study Completion Date : July 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Acne Scars

Arm Intervention/treatment
Experimental: needling treatment
Needling treatment applied to half of the face at each study visit
Procedure: needling treatment
Needling treatment applied to half of the face at each study visit

No Intervention: Control
No treatment applied to half of the face

Primary Outcome Measures :
  1. We will evaluate qualitatively and quantitatively the improvement of the subject's acne scars [ Time Frame: 6 months ]

Secondary Outcome Measures :
  1. The tolerability of the treatment will be assessed [ Time Frame: 4 weeks ]
  2. Subject satisfaction will be determined [ Time Frame: 6 months ]
  3. Any adverse events of this treatment will be recorded. [ Time Frame: 6 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Ages 18-70 years old
  • Subjects in general good health
  • The subject has the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator
  • Global Acne Scarring Classification grade 2-41 (Appendix II)
  • Subject has at least two areas of acne scaring on the face (with at least 2 acne scars in each) that are at least 2 cm apart

Exclusion Criteria:

  • Pregnancy and lactation
  • Subjects with history of keloid or hypertrophic scars
  • Subjects with active skin disease (other than mild acne) or skin infection in the treatment area
  • Subjects with an active systematic or local skin disease that is likely to alter wound healing
  • Subjects who have undergone in the past 6 months or planning to undergo in the next 6 months the following cosmetic treatments in the acne scar area

    • Injectable permanent filler
    • Ablative laser treatment
  • Subjects taking the following prescription medications:

    • Accutane or other retinoids within the past 12 months
    • Anticoagulant (warfarin)
  • Subjects who allergic to lidocaine and prilocaine

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00974870

Layout table for location information
United States, Illinois
Northwestern University Feinberg School of Medicine, Department of Dermatology
Chicago, Illinois, United States, 60611
Sponsors and Collaborators
Northwestern University
Layout table for investigator information
Principal Investigator: Murad Alam, MD Northwestern University
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Murad Alam, Professor in Dermatology, Otolaryngology- Head and Neck Surgery, and Surgery-Organ Transplantation, Northwestern University
ClinicalTrials.gov Identifier: NCT00974870    
Other Study ID Numbers: STU15904
First Posted: September 10, 2009    Key Record Dates
Last Update Posted: December 2, 2021
Last Verified: November 2021
Additional relevant MeSH terms:
Layout table for MeSH terms
Acne Vulgaris
Acneiform Eruptions
Skin Diseases
Sebaceous Gland Diseases